|
Re: Trial Status
|
3
|
Resverlogix Corp.
|
Jul 20, 2021 06:19PM
|
|
Re: the bid/asks haven't moved since the news came out...
|
3
|
Resverlogix Corp.
|
Feb 03, 2020 11:00AM
|
|
Re: Interesting turn of phrase in today's PR....
|
3
|
Resverlogix Corp.
|
Nov 13, 2019 10:10AM
|
|
Re: Compounds and Autoimmune
|
3
|
Resverlogix Corp.
|
Jun 21, 2016 05:23PM
|
|
Re: Bloom Burton Slides
|
3
|
Resverlogix Corp.
|
May 02, 2018 04:38PM
|
|
Re: Israeli Researchers Identify COVID-19 Proteins that Damage Blood Vessels.
|
3
|
Resverlogix Corp.
|
Nov 04, 2021 10:35AM
|
|
Re: Beacon report
|
3
|
Resverlogix Corp.
|
Nov 17, 2017 03:07PM
|
|
Re: What am I missing
|
3
|
Resverlogix Corp.
|
Nov 26, 2021 12:14PM
|
|
Re: BET inhibitor and BRD4 papers keep piling up
|
3
|
Resverlogix Corp.
|
Sep 24, 2017 11:23AM
|
|
Re: Epigenetics market size
|
3
|
Zenith Epigenetics
|
Jan 25, 2024 11:48AM
|
|
Re: FDA approves drug that reduces MACE in Diabetes patients (Forbes)
|
3
|
Resverlogix Corp.
|
Jun 15, 2016 09:16AM
|
|
Re: What would an update really tell us?
|
3
|
Resverlogix Corp.
|
Jul 19, 2015 02:20PM
|
|
Financing curiousity
|
3
|
Resverlogix Corp.
|
Jan 26, 2018 09:55AM
|
|
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
|
3
|
Zenith Epigenetics
|
Feb 08, 2019 03:26PM
|
|
Liquidity
|
3
|
Zenith Epigenetics
|
Aug 01, 2019 02:15PM
|
|
FDA fast track
|
3
|
Resverlogix Corp.
|
Jul 09, 2015 01:12PM
|
|
GV and BoM
|
3
|
Resverlogix Corp.
|
Sep 01, 2017 05:20PM
|
|
Re: Warning: Long - Thoughts on Management
|
3
|
Resverlogix Corp.
|
Mar 30, 2021 05:31PM
|
|
AGM
|
3
|
Zenith Epigenetics
|
Oct 04, 2021 11:43AM
|
|
Re: Zenith funding???
|
3
|
Zenith Epigenetics
|
Jun 24, 2019 04:43PM
|
